New investigational drug for treatment of Myelofibrosis

Trial ID:
IRB-24-8484
Marin Xavier, MD

Inclusion Criteria

Patients must:

  • Be 18 years or older
    Have confirmed diagnosis of Myelofibrosis
    Be able to complete study questionnaires

Exclusion Criteria

Patients must not:

  • Have prior therapy with any JAK inhibitor
    Have prior splenectomy
    Have history of solid organ transplant
    Have other malignancy within the last three years

Additional Info

All treatments and physician visits during this study will take place at Prebys Cancer Center in Hillcrest.

For more information search NCT#: 06479135 at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Services
  • crsleadership@scrippshealth.org